Skip to main content
. Author manuscript; available in PMC: 2011 Nov 20.
Published in final edited form as: J Clin Endocrinol Metab. 2006 May 30;91(8):2931–2937. doi: 10.1210/jc.2005-2818

TABLE 1C.

Clinical characteristics of women with AN not receiving oral contraceptives, categorized by the presence or absence of improved weight at subsequent visits

Improved weight (n = 22)
Did not improve weight (n = 23)
First visit Second visit % Change between visits First visit Second visit % Change between visits
Age (yr) 23.6 ± 1.0 25.5 ± 1.3
Age of menarche (yr) 13.4 ± 0.3 12.7 ± 0.38
Weight (kg) 42.9 ± 1.6 48.5 ± 1.5 13.7 ± 1.9a 44.3 ± 1.3 44.7 ± 1.3 1.0 ± 1.2
Ideal body weight (%) 74.7 ± 1.6 83.1 ± 1.3a 75.1 ± 1.4 75.5 ± 1.3
Body mass index (kg/m2) 16.2 ± 0.4 18.2 ± 0.4a 16.5 ± 0.4 16.6 ± 0.3
Total fat (kg) 7.9 ± 0.9 11.1 ± 0.8a 57.7 ± 10.2a 7.5 ± 0.7 8.5 ± 0.7 24.8 ± 14.7
Fat-free mass (kg) 32.4 ± 1.0 34.1 ± 0.9 8.4 ± 1.5a 34.3 ± 1.2 34.7 ± 1.1 0.5 ± 1.4
Mean PA spine T score −2.0 ± 0.2 −2.1 ± 0.2 −1.8 ± 0.2 −2.0 ± 0.2
PA spine BMD 0.82 ± 0.02 0.82 ± 0.02 −0.2 ± 1.4 0.84 ± 0.02 0.8 ± 0.02 −1.8 ± 1.0
Mean hip T score −1.5 ± 0.2 −1.5 ± 0.2 −1.5 ± 0.2 −1.6 ± 0.2
Hip BMD 0.76 ± 0.03 0.77 ± 0.03 0.6 ± 1.0a 0.78 ± 0.03 0.76 ± 0.03 −2.9 ± 1.0
Resumption of menstrual function (%) 31.8 17.4
Mean length of follow-up visit (months) [range] 16.9 ± 2.8 (6–69) 13.3 ± 1.1 (7–29)

Improved weight: at subsequent visit, increased body weight by at least 10% or to more than 85% of ideal body weight.

a

P ≤ 0.05 vs. non-weight-improved group.